These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9495263)
1. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME. Francischetti A; Ono H; Frohlich ED Hypertension; 1998 Mar; 31(3):795-801. PubMed ID: 9495263 [TBL] [Abstract][Full Text] [Related]
2. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats. Ono H; Ono Y; Frohlich ED Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats. Nakamura Y; Ono H; Frohlich ED Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Nakamura Y; Ono H; Zhou X; Frohlich ED Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938 [TBL] [Abstract][Full Text] [Related]
5. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR. Zhou X; Matavelli LC; Ono H; Frohlich ED Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021 [TBL] [Abstract][Full Text] [Related]
6. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model. Zhou X; Ono H; Ono Y; Frohlich ED J Hypertens; 2002 May; 20(5):993-1000. PubMed ID: 12011661 [TBL] [Abstract][Full Text] [Related]
7. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats. Ono Y; Ono H; Frohlich ED J Hypertens; 1996 Jul; 14(7):823-8. PubMed ID: 8818920 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats. Susic D; Varagic J; Frohlich ED J Hypertens; 1999 Aug; 17(8):1209-15. PubMed ID: 10466478 [TBL] [Abstract][Full Text] [Related]
9. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertension. Jover B; Herizi A; Casellas D; Mimran A J Hypertens; 2001 Nov; 19(11):2039-46. PubMed ID: 11677370 [TBL] [Abstract][Full Text] [Related]
10. Renoprotective effects of omapatrilat are mediated partially by bradykinin. Zhou X; Ono H; Ono Y; Frohlich ED Am J Nephrol; 2003; 23(4):214-21. PubMed ID: 12789027 [TBL] [Abstract][Full Text] [Related]
11. Effect of the antihypertensive drug enalapril on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat. Chandran G; Sirajudeen KN; Yusoff NS; Swamy M; Samarendra MS Oxid Med Cell Longev; 2014; 2014():608512. PubMed ID: 25254079 [TBL] [Abstract][Full Text] [Related]